Researchers develop peptide that can target tumors, deliver agents

10/27/2009 | EurekAlert!

Two University of Rhode Island researchers have developed a peptide called pHLIP that was able to locate a tumor in a mouse then deliver imaging and therapeutic agents to the cancer cells without harming surrounding healthy cells. The peptide's delivery method involves the use of a molecular nanosyringe that can deliver nanogold particles directly to the cancerous tumors. The technology has a pending patent in the U.S. and Europe.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY